Doxycycline vs Upadacitinib
Doxycycline vs Upadacitinib: Overview
This comparison examines the pharmacological differences between Doxycycline and Upadacitinib.
Mechanism of Action
Doxycycline: Inhibits bacterial protein synthesis by binding 30S ribosomal subunit.
Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.
Pharmacokinetics
Half-life: Doxycycline β 18-22 hours; Upadacitinib β 9-14 hours.
Chemical Properties
Molecular Formula: Doxycycline β C22H24N2O8; Upadacitinib β C17H19F3N6O.
Molecular Weight: Doxycycline β 444.4350 g/mol; Upadacitinib β 380.3700 g/mol.
Type: Doxycycline β Small molecule; Upadacitinib β Small molecule.